Logo Main Camp : GPS Coordinates -29.1321686 - 153.065696

Main Camp

Seoul-based Cenyx operates an advanced cosmetic lab developing nanomedicine solutions through proprietary CX synthesis technology for inflammatory diseases treatment.

Presentation of Main Camp

Located in Seoul, South Korea, cosmetic lab Cenyx advances nanomedicine through its proprietary CX synthesis platform. Since 2016, the lab specializes in:

  • Nanozyme development for inflammatory diseases
  • Biotech agents for nervous system treatments
  • Clinical research and drug pipeline programs
  • Enzymatic reaction optimization

With orphan drug designation granted in 2025, Cenyx continues expanding its therapeutic applications in the growing South Korean biotech sector.

Main Camp newsfeed

  • Cenyx has not yet been verified. The newsfeed is disabled.

Detailed presentation of Main Camp

Innovative biotech solutions at Cenyx

Founded in 2016, Cenyx operates from Seoul, South Korea, as a pioneering biotechnology company. Starting as a cosmetic lab, the company has evolved into a leader in nanomedicine development.

Advanced technological capabilities

At the core of Cenyx’s operations is their proprietary CX synthesis platform, which enables the development of specialized nanozymes. The company has created innovative nano-biotech agents with unique capabilities in managing oxidative stress through the removal of multiple radical compounds.

Research and development focus

  • Development of therapeutic nanozymes
  • Management of inflammatory conditions
  • Nervous system disease treatments
  • Advanced enzymatic reaction research

Strategic location in South Korea’s biotech hub

Based in Seoul’s biotechnology district, Cenyx benefits from South Korea’s advanced pharmaceutical research infrastructure. This location positions the company within a network of leading research institutions and medical facilities.

Current developments and achievements

The company maintains four active pipeline programs targeting both acute and chronic inflammatory conditions. In early 2025, Cenyx received orphan designation status, marking a significant milestone in their drug development journey.

Areas of specialization

  • Nanozyme technology implementation
  • Therapeutic applications development
  • Clinical trials management
  • Biotech agent optimization

Future directions

Cenyx continues to expand its drug pipeline while strengthening its position in the South Korean biotech sector. The company’s work in nervous system disease treatment represents a growing focus area within their research portfolio.

Services provided by Main Camp

Below you will find the services provided by Cenyx. Like each cosmetic lab on the platform, the services are manually registered by the providing company.

  • Cenyx has no service catalogue on cosmetic-labs.com.

Gallery and medias

  • Cenyx has not yet posted any media. There is no gallery yet.

Locate Main Camp

Contact Main Camp

  • Cenyx has not yet been verified. Messaging is disabled.

Main Camp opening hours

Closed all day

  • Monday

    Closed all day
  • Tuesday

    Closed all day
  • Wednesday

    Closed all day
  • Thursday

    Closed all day
  • Friday

    Closed all day
  • Saturday

    Closed all day
  • Sunday

    Closed all day
  • Local time

    September 23, 2025 1:45 am

Frequent questions

Cenyx focuses on the following areas:

  • Nanozyme Technology
    • CX synthesis platform
    • Nano-biotech agents
    • Enzymatic reaction catalysts
  • Disease Treatment
    • Inflammatory disease therapies
    • Nervous system treatments
    • Drug development programs
  • Research Programs
    • Clinical trials
    • Pharmaceutical studies
    • Drug pipeline development

The company operates under pharmaceutical industry regulations and standards.

Cenyx focuses on the following areas:

  • Nanozyme Technology
    • CX synthesis platform
    • Nano-biotech agents
    • Enzymatic reaction catalysts
  • Disease Treatment
    • Inflammatory disease therapies
    • Nervous system treatments
    • Drug development programs
  • Research Programs
    • Clinical trials
    • Pharmaceutical studies
    • Drug pipeline development

The company operates under pharmaceutical industry regulations and standards.

Cenyx focuses on the following areas:

  • Nanozyme Technology
    • CX synthesis platform
    • Nano-biotech agents
    • Enzymatic reaction catalysts
  • Disease Treatment
    • Inflammatory disease therapies
    • Nervous system treatments
    • Drug development programs
  • Research Programs
    • Clinical trials
    • Pharmaceutical studies
    • Drug pipeline development

The company operates under pharmaceutical industry regulations and standards.

Explore

Find a cosmetic lab in Australia

Click below to see the profile of a cosmetic lab similar to Main Camp in Australia.

Guangrao Liuhe Chemical in Shandong, China manufactures guar gum products and runs testing facilities serving food, cosmetic, mining and industrial sectors.
Dinaco operates a cosmetic lab and chemical distribution network from São Paulo, serving Brazilian industries since 1937 with technical expertise and certified facilities.
Samkyung Costech operates cosmetic research facilities in Suwon and Jecheon, South Korea, specializing in natural oil emulsion technology and sustainable ingredients.
Upcycled Beauty’s cosmetic lab in England manufactures sustainable beauty ingredients from plant-based waste materials, offering certified product ranges since 2017.
PT. Tanimas Yuanyi World manufactures surfactants from palm kernel oil in Medan, Indonesia, supplying raw materials for personal care products across Asia.
Precheza, a leading European titanium dioxide manufacturer in Czechia, produces high-grade materials for cosmetics, pharmaceuticals and industrial applications.